The Scientist - Home

Scientists are exploring why high temperatures may increase brain stroke risk, who is most at risk, and how the threat may grow in a warming world.

Thousands of cyclosporiasis cases across dozens of US states triggered investigations, but the exact contamination source remains elusive.

A new peptide-based vaccine elicited antigen-specific T cell responses in high-risk patients, demonstrating proof of concept for PDAC intervention. 

This postdoctoral researcher studies the complex structural domains of long non-coding RNAs to uncover targetable heterogeneities in breast cancer.

A new AAV-based gene therapy successfully improved seizures, behavior, and brain activity in fragile X syndrome mice, paving the way for clinical development.

Jennifer Doudna's new AI-designed CRISPR-Cas12 nuclease outperformed its natural counterpart.

Improving macrophage-mediated senescent neutrophil clearance in mice prevented age-related decline, offering potential targets for antiaging therapies.

A brain-computer interface paired with electrical stimulation patches helped a paralyzed man regain hand strength, dexterity, and his sense of touch.

Using a protein large language model, researchers reconstructed the T. rex collagen type 1 protein sequence, which they then expressed and manufactured into leather.

AI giant Anthropic recently announced its scientific workbench, Claude Science. While scientists praised many of its features, they noted that its reasoning needs work.

An engineered enzyme cleaved and repaired age-related protein damage in human tissue, which was long thought to be irreversible in a proof-of-concept study.

Chronic iron exposure weakened antioxidant defenses in neurons without killing them, creating a vulnerable state that could help explain neurodegeneration.